Paris based Enterome has an IO approach that is founded on learnings from how the gut interacts with the immune system
CEO Pierre Belichard describes the scientific underpinnings of this idea, and how it has lead to Enterome's programs, including one in NHL that has caught the attention of the Leukemia & Lymphoma Society and will have data around ASH time.